CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 83 filers reported holding RAPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,686,133
-0.4%
221,789
+12.1%
0.00%0.0%
Q2 2023$3,699,702
+3.4%
197,845
+1.5%
0.00%0.0%
Q1 2023$3,577,626
+5.6%
194,966
+13.9%
0.00%0.0%
Q4 2022$3,389,503
-15.4%
171,187
+2.8%
0.00%0.0%
Q3 2022$4,006,000
+44.0%
166,487
+9.2%
0.00%0.0%
Q2 2022$2,782,000
-13.3%
152,418
+4.5%
0.00%0.0%
Q1 2022$3,207,000
-38.6%
145,818
+2.6%
0.00%
-50.0%
Q4 2021$5,219,000
+19.9%
142,073
+1.4%
0.00%
+100.0%
Q3 2021$4,352,000
+69.5%
140,134
+73.5%
0.00%0.0%
Q2 2021$2,568,000
+75.2%
80,760
+22.4%
0.00%0.0%
Q1 2021$1,466,000
+11.8%
66,003
-0.5%
0.00%0.0%
Q4 2020$1,311,000
-37.7%
66,345
+1.4%
0.00%0.0%
Q3 2020$2,106,000
+40.2%
65,397
+26.4%
0.00%0.0%
Q2 2020$1,502,000
+138.0%
51,756
+74.7%
0.00%
Q1 2020$631,000
+40.8%
29,632
+82.9%
0.00%
Q4 2019$448,00016,1970.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders